New Year Address of Beroni Group

About
R&D
Core Businesses
Products
Investors
News
Contact
English

Menu

Home>
2018>
December>
29>
2018>
New Year Address of Beroni Group

New Year Address of Beroni Group

admin
2018-12-29
2018

You Might Also Like

Professor Walter Ian Lipkin of Columbia University visited Beroni Group

2018-06-14

Statements on “China-Japan Belt and Road Forum”

2018-07-20

Beroni Group signed an agreement with I’rom Group

2018-08-22

Search Article

Arrange by Year

2017 (10)
2018 (25)
2019 (25)
2020 (13)

What’s New

Beroni Group Announces Successful Completion of SARS-CoV-2 Pseudovirus Neutralization Assay for Treatment of COVID-19
Beroni Group Collaborates with Genscript Biotech Corporation
Beroni Group to Supply COVID-19 Antibody Test Kit to Japan
Representatives of Huarong Securities Co., Ltd Visit Beroni Group
Strategic Cooperation between Beroni Group and BG Health

Beroni Group is an international biotechnological company listed on the National Stock Exchange (Australia) and traded on the OTC markets in the USA with business presence in Australia, China, Japan and the USA. It currently has four core businesses – research and development of new drugs and clinical trial, immune cell therapy including gene detection and diagnosis, immunotherapy for cancer treatment, diagnosis of infectious diseases and e-commerce based on the Internet sales of pharmaceutical, healthcare and cosmetic products.

About

About Beroni
Our History
Board of Directors
Management Team
Vision, Mission, and Values

Core Businesses

Cell Therapy
Anti-Cancer Drugs
Infectious Diseases
E-Commerce

Products

By Beroni China
By Beroni Japan
By Beroni USA
By Medicine Plus

website by chase e-Design

Close Menu